FindMyKOL

Elizabeth Juneman, MD

Basic profile

University of Arizona

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionTucson, AZ · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Elizabeth Juneman is a Cardiology physician affiliated with University of Arizona. OpenAlex indexes 91 publications with 774 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
91publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

774citations

Citations across these publications.

15h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Abbott Laboratories
    Program year20252 payments
    $78
  • Bristol Myers Squibb
    Program year20241 paymentResearch
    $15,531
  • Bristol Myers Squibb
    Program year20231 paymentResearch
    $36,711
All 9 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    56.9%
    Statin13.1%
    Rosuvastatin Calcium57%Atorvastatin Calcium43%
    Part D≥26 patients
    Beta blocker9%
    Carvedilol48%Metoprolol Succinate38%Metoprolol Tartrate14%
    Part D<11 patients

    + 8 more classes in this area

  • Cancer & immunology

    16.1%
    Calcineurin inhibitor12%
    Tacrolimus81%Cyclosporine Modified19%
    Part D<11 patients
    Kinase inhibitor4.1%
    Sirolimus100%
    Part D≥13 patients
  • Metabolism & gastrointestinal

    12.9%
    SGLT2 inhibitor6%
    Farxiga73%Jardiance27%
    Part D<11 patients
    Corticosteroid2.9%
    Prednisone100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)21.9% facility · 78.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”